참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Imatinib | HCID 5291 | — |
| 반응물 | Methanesulfonic Acid | HCID 6395 | — |
| 반응물 | 1-Methoxyethanol | HCID 3015637 | — |
| 반응물 | 1-Ethoxyethanol | HCID 10129898 | — |
| 용매 | Methanol | HCID 887 | — |
| 용매 | Acetonitrile | HCID 6342 | — |
| 용매 | Nitromethane | HCID 6375 | — |
| 용매 | Propylene Carbonate | HCID 7924 | — |
| 용매 | N-methyl-2-pyrrolidone | HCID 13387 | — |
| 생성물 | Imatinib Mesylate | HCID 123596 | — |
반응 단계
Alternatively, the solution may be prepared by admixing imatinib base, methanesulfonic acid and a solvent selected from the group consisting of: methanol, methoxyethanol or ethoxyethanol, N-methylpyrrolidone, propylene carbonate, acetonitrile, nitromethane to obtain a mixture; and heating the mixture to obtain an imatinib mesylate solution. Heating the mixture to obtain an imatinib mesylate solution is preferably to a temperature of about 20° C. to about 85° C., more preferably of about 60° C. to about 80° C. Preferably, the obtained solution is further cooled to a temperature of about 20° C. to about 0° C. prior to the addition of the anti-solvent. Preferably the solution of imatinib mesylate is gradually added to the anti-solvent under stirring. Preferably, the solution of imatinib mesylate is added to an excess of anti-solvent.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08067421B2 |
|---|
| 출처 데이터셋 | uspto-grants-2011_11 |
|---|
| ORD ID | ord-c47d0b859c424b8288f13b2b12baf475 |
|---|
| 출처 메모 | uspto-grants-2011_11 |
|---|